Skip to main content
Terug
Watch Compare

RESMED INC

Datakwaliteit: 100%
RSMDF
NYSE Manufacturing Measuring & Analyzing Instruments
€ 19,66
€ 0,00 (0,00%)
Marktkapitalisatie: 28,64 B
Prijs
€ 19,66
Marktkapitalisatie
28,64 B
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 12,64% annually over 5 years — strong growth
Earnings grew 37,20% over the past year
ROE of 23,88% indicates high profitability
Net margin of 27,53% shows strong profitability
Debt/Equity of 0,11 — conservative balance sheet
Generating 1,79 B in free cash flow

Groei

Revenue Growth (5Y)
12,64%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)9,84%
Earnings (1Y)37,20%
FCF Growth (3Y)70,20%

Kwaliteit

Return on Equity
23,88%
Boven sectorgemiddelde (-53,34%)
ROIC20,05%
Net Margin27,53%
Op. Margin33,70%

Veiligheid

Debt / Equity
0,11
Onder sectorgemiddelde (0,31)
Current Ratio3,06
Interest CoverageN/A

Waardering

PE (TTM)
19,28
Boven sectorgemiddelde (-1,47)
P/B Ratio4,53
EV/EBITDA13,78
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E 19,3 -1,5
P/B 4,5 1,6
ROE % 23,9 -53,3
Net Margin % 27,5 -41,5
Rev Growth 5Y % 12,6 1,8
D/E 0,1 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 — 6,06 B —
FY2026 — 5,64 B —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 9,84% Revenue Growth (3Y) 10,39%
Earnings Growth (1Y) 37,20% Earnings Growth (3Y) 24,92%
Revenue Growth (5Y) 12,64% Earnings Growth (5Y) 31,08%
Profitability
Revenue (TTM) 5,40 B Net Income (TTM) 1,49 B
ROE 23,88% ROA 17,68%
Gross Margin 60,87% Operating Margin 33,70%
Net Margin 27,53% Free Cash Flow (TTM) 1,79 B
ROIC 20,05% FCF Growth (3Y) 70,20%
Safety
Debt / Equity 0,11 Current Ratio 3,06
Interest Coverage N/A Asset Turnover 0,64
Working Capital 2,57 B Tangible Book Value 2,85 B
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 19,28 Forward P/E N/A
P/B Ratio 4,53 P/S Ratio 5,31
PEG Ratio 0,62 Forward PEG N/A
EV/EBITDA 13,78 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 6,26%
Market Cap 28,64 B Enterprise Value 27,89 B
Per Share
EPS (Diluted TTM) 10,11 Revenue / Share 3,71
FCF / Share 1,23 OCF / Share 1,31
EPS CAGR (1Y) 37,43% EPS CAGR (5Y) 30,89%
EPS CAGR (10Y) 16,06%
Efficiency
CapEx / Revenue 2,28% FCF Conversion 120,58%
SBC-Adj. FCF 1,70 B Growth Momentum -2,80

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5,15 B 4,69 B 4,22 B 3,58 B 3,20 B
Net Income 1,40 B 1,02 B 897,56 M 779,44 M 474,51 M
EPS (Diluted) 9,51 6,92 6,09 5,30 3,24
Gross Profit 3,05 B 2,66 B 2,36 B 2,02 B 1,84 B
Operating Income 1,69 B 1,32 B 1,13 B 1,00 B 903,68 M
EBITDA — — — — —
R&D Expenses 331,28 M 307,53 M 287,64 M 253,58 M 225,28 M
SG&A Expenses 991,02 M 917,14 M 874,00 M 739,37 M 670,39 M
D&A 198,47 M 176,87 M 165,16 M 159,61 M 156,76 M
Interest Expense — — -47,38 M -22,31 M 23,99 M
Income Tax 276,84 M 243,85 M 204,11 M 181,05 M 409,16 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,17 B 6,87 B 6,75 B 5,10 B 4,73 B
Total Liabilities 2,21 B 2,01 B 2,62 B 1,74 B 1,84 B
Shareholders' Equity 5,97 B 4,86 B 4,13 B 3,36 B 2,89 B
Total Debt 668,29 M 707,21 M 1,44 B 775,24 M 655,35 M
Cash & Equivalents 1,21 B 238,36 M 227,89 M 273,71 M 295,28 M
Current Assets 3,51 B 2,36 B 2,37 B 1,93 B 1,57 B
Current Liabilities 1,02 B 910,66 M 758,53 M 689,30 M 911,77 M